Healthcare provider profile · identity verified

Jodi A Newcombe, M.D.

Family Practice · YARMOUTH, ME · NPI 1114339611

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	433	120
Levothyroxine Sodium	Levothyroxine Sodium	322	91
Losartan Potassium	Losartan Potassium	288	94
Lisinopril	Lisinopril	281	91
Amlodipine Besylate	Amlodipine Besylate	257	80
Hydrochlorothiazide	Hydrochlorothiazide	242	78
Rosuvastatin Calcium	Rosuvastatin Calcium	202	66
Omeprazole	Omeprazole	192	51
Metoprolol Succinate	Metoprolol Succinate	168	50
Simvastatin	Simvastatin	148	44
Gabapentin	Gabapentin	139	55
Tamsulosin Hcl	Tamsulosin Hcl	111	34
Metformin Hcl Er	Metformin Hcl	109	31
Trazodone Hcl	Trazodone Hcl	103	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	19
Sertraline Hcl	Sertraline Hcl	92	29
Metformin Hcl	Metformin Hcl	86	27
Escitalopram Oxalate	Escitalopram Oxalate	85	26
Metoprolol Tartrate	Metoprolol Tartrate	85	24
Furosemide	Furosemide	84	31
Pravastatin Sodium	Pravastatin Sodium	81	24
Albuterol Sulfate Hfa	Albuterol Sulfate	80	40
Pantoprazole Sodium	Pantoprazole Sodium	76	21
Eliquis	Apixaban	69	20
Montelukast Sodium	Montelukast Sodium	61	14
Oxycodone Hcl	Oxycodone Hcl	61	14
Atenolol	Atenolol	56	18
Lorazepam	Lorazepam	55	21
Allopurinol	Allopurinol	54	19
Carvedilol	Carvedilol	53	17
Clonazepam	Clonazepam	52	suppressed
Glipizide Er	Glipizide	52	15
Mirtazapine	Mirtazapine	50	16
Duloxetine Hcl	Duloxetine Hcl	49	16
Synthroid	Levothyroxine Sodium	46	12
Bupropion Xl	Bupropion Hcl	45	17
Famotidine	Famotidine	45	14
Mounjaro	Tirzepatide	45	suppressed
Buspirone Hcl	Buspirone Hcl	44	15
Jardiance	Empagliflozin	42	13
Tramadol Hcl	Tramadol Hcl	42	12
Ozempic	Semaglutide	40	suppressed
Chlorthalidone	Chlorthalidone	39	13
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Prednisone	Prednisone	36	26
Zolpidem Tartrate	Zolpidem Tartrate	36	15
Trulicity	Dulaglutide	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	12
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Spironolactone	Spironolactone	30	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Amoxicillin	Amoxicillin	27	22
Januvia	Sitagliptin Phosphate	27	suppressed
Methylprednisolone	Methylprednisolone	27	22
Triamcinolone Acetonide	Triamcinolone Acetonide	27	17
Valacyclovir	Valacyclovir Hcl	27	18
Alendronate Sodium	Alendronate Sodium	26	11
Celecoxib	Celecoxib	26	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Meloxicam	Meloxicam	24	14
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Potassium Chloride	Potassium Chloride	23	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Baclofen	Baclofen	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	17
Azithromycin	Azithromycin	17	16
Bumetanide	Bumetanide	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Diazepam	Diazepam	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Topiramate	Topiramate	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Nystatin	Nystatin	15	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Estradiol	Estradiol	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Finasteride	Finasteride	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Enalapril Maleate	Enalapril Maleate	12	suppressed
Lactulose	Lactulose	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error